SIGLEC (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "SIGLEC" in Japanese language version.

refsWebsite

Global rank Japanese rank

10nih.gov

4^th place

24^th place

9doi.org

2^nd place

6^th place

doi.org (Global: 2^nd place; Japanese: 6^th place)

Crocker P (1986). “Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages”. J Exp Med 164 (6): 1862–75. doi:10.1084/jem.164.6.1862. PMC 2188478. PMID 3783087.
Crocker P (2001). “Siglecs in the immune system”. Immunology 103 (2): 137–45. doi:10.1046/j.0019-2805.2001.01241.x. PMC 1783234. PMID 11412300.
Varki A (2006). “Siglecs-the major subfamily of I-type lectins”. Glycobiology 16: 1R-27R. doi:10.1093/glycob/cwj008. PMID 16014749.
Avril T (2004). “The Membrane-Proximal Immunoreceptor Tyrosine-Based Inhibitory Motif is critical for the Inhibitory Signaling Mediated by Siglecs-7 and -9, CD33-Related Siglecs Expressed on Human Monocytes and NK Cells”. The Journal of Immunology 173: 6841–6849. doi:10.4049/jimmunol.173.11.6841. PMID 15557178.
Razi N (1999). “Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation”. Glycobiology 9: 1225–1234. doi:10.1093/glycob/9.11.1225. PMID 10536038.
Mitra N (2011). “SIGLEC12, a Human-specific Segragating (Pseudo)gene, Encodes a Signaling Molecule Expressed in Prostate Carcinomas”. J. Biol. Chem. 286: 23003–23011. doi:10.1074/jbc.M111.244152. PMC 3123068. PMID 21555517.
Wang X (Jun 19, 2012). “Specific inactivation of two immunomodulatory SIGLEC genes during human evolution”. Proc Natl Acad Sci U S A. 109 (25): 9935–40. doi:10.1073/pnas.1119459109.
Angata T (2007). “Siglec-15: an immune system Siglec conserved throughout vertebrate evolution”. Glycobiology 17: 838–846. doi:10.1093/glycob/cwm049. PMID 17483134.
Cao H1, Lakner U, de Bono B, Traherne JA, Trowsdale J, Barrow AD. (Aug 2008). “SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans”. Eur J Immunol. 38 (8): 2303–15. doi:10.1002/eji.200738078.

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

Crocker P (1986). “Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages”. J Exp Med 164 (6): 1862–75. doi:10.1084/jem.164.6.1862. PMC 2188478. PMID 3783087.
Crocker P (2001). “Siglecs in the immune system”. Immunology 103 (2): 137–45. doi:10.1046/j.0019-2805.2001.01241.x. PMC 1783234. PMID 11412300.
Varki A (2006). “Siglecs-the major subfamily of I-type lectins”. Glycobiology 16: 1R-27R. doi:10.1093/glycob/cwj008. PMID 16014749.
Avril T (2004). “The Membrane-Proximal Immunoreceptor Tyrosine-Based Inhibitory Motif is critical for the Inhibitory Signaling Mediated by Siglecs-7 and -9, CD33-Related Siglecs Expressed on Human Monocytes and NK Cells”. The Journal of Immunology 173: 6841–6849. doi:10.4049/jimmunol.173.11.6841. PMID 15557178.
Razi N (1999). “Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation”. Glycobiology 9: 1225–1234. doi:10.1093/glycob/9.11.1225. PMID 10536038.
Mitra N (2011). “SIGLEC12, a Human-specific Segragating (Pseudo)gene, Encodes a Signaling Molecule Expressed in Prostate Carcinomas”. J. Biol. Chem. 286: 23003–23011. doi:10.1074/jbc.M111.244152. PMC 3123068. PMID 21555517.
Angata T (2007). “Siglec-15: an immune system Siglec conserved throughout vertebrate evolution”. Glycobiology 17: 838–846. doi:10.1093/glycob/cwm049. PMID 17483134.

SIGLEC (Japanese Wikipedia)

doi.org (Global: 2nd place; Japanese: 6th place)

nih.gov (Global: 4th place; Japanese: 24th place)

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

doi.org (Global: 2^nd place; Japanese: 6^th place)

nih.gov (Global: 4^th place; Japanese: 24^th place)